LPA can increase glycodelin expression in cervical cancer (Hela cells), endometrial cancer (RL-95 cells), and ovarian cancer (OVCAR-3 cells) but not in breast cancer (MDA-MB-231 cells) (96), which further implies that glycodelin may be involved in LPA-induced signaling to participate in cancer development and progression. Here, PAEP is linked to ovarian cancer.